Back to search

University of Ioannina

Μεταβολικό σύνδρομο και οστική νόσος σε ασθενείς με χρόνια νεφρική νόσο

Abstract

dc:description

Background. The incidence of obesity and MS has reached epidemic proportions and is a significant public health problem. Among their many effects on the human body are those on bone metabolism markers, notably vitamin D and parathyroid hormone (PTH). On the other hand, bone and mineral metabolism disorders are a prevalent complication of CKD. Purpose. The study aimed to investigate the effect of obesity and MS on bone metabolism markers and primarily on the levels of vitamin D metabolites [25(OH)D and 1.25(OH)2D] and PTH. In the present study, we have evaluated the effect on the same factors of chronic kidney disease (CKD). Methods. The study consists of two parts. In part one, 104 individuals with a high body mass index (BMI>25kg/m2) were studied, which, according to WHO guidelines, regarded as the threshold to be considered overweight. Participants were divided into 3 groups according to the level of estimated glomerular filtration rate (eGFR-MDRD ml / min / 1.73m2): G1 ≥ 60 (n = 53), G2 30–59 (n = 35) and G3 15–29 (n = 16). Fifty individuals with BMI>25kg/m2 and corresponding eGFR levels were the control group: G1-nw (n = 23), G2-nw (n = 18) and G3-nw (n = 9). In part two, we explored the effect of MS on bone metabolism indices. Firstly, we studied the effect of MS on bone metabolism markers in 83 adult patients with CKD defined as a decrease in eGFR below 60 ml/min/1.73m2. Patients were divided into two groups according to the presence (n = 56) or not (n = 27) of MS. Secondly, we examined the effect of CKD on bone metabolism markers in 112 adult subjects with MS separated in two groups of 56 individuals each depending on the presence of eGFR <60 ml/min/1.73m2. Results. Part 1. The mean serum 25(OH)D value of subjects with BMI> 25kg/m2 was 19.9 ± 6.4ng / ml and was significantly different from that of normal subjects (24.9±6.3ng/ml, p<0.001). Overweight/obese participants had lower serum 25(OH)D levels than subjects with BMI <25kg/m2 at all glomerular filtration levels. In contrast, levels of the active form of 1.25(OH)2D were comparably similar between overweight / obese in both total [48.4 (34.2, 60.9) pg / ml versus 46.3 (38.7, 60.9) pg / ml, as in all subgroups and the same was observed with parathyroid hormone. The presence of increased body weight did not differentiate calcium and phosphorus levels. In all G1-G3 groups, the mean serum 25(OH)D concentration was below the recommended levels (30ng/ml): 97 of the 104 subjects (93%) had levels below the above value. Although in the control group the deficiency of 25(OH)D was significantly less in both the total (74%, p <0.001) and the subgroups, only 1 out of 4 had sufficient levels. All patients with stage 4 CKD had insufficient levels of 25(OH)D irrespective of BMI. Increased BMI, female sex and reduced eGFR were independently associated with low 25(OH)D levels. Decreased eGFR and elevated serum phosphorus levels had a positive effect on PTH and a negative on 1.25(OH)2D. Compared to overweight / obese but normal fasting glucose (NFG) subjects, patients with diabetes had lower 25(OH)D (17.8±5.6 versus 21.0±6.5 ng/ml, p = 0.035), and 1.25( OH)2D [40.9 (31.4, 56.0) vs. 53.8 (43.3, 67.9) pg / ml, p = 0.031] and higher levels of parathyroid hormone [82.0 (55.3, 127.0) vs. 55.79 (48.0, 97.0) pg/ml, p = 0.041 ]. Besides, only one of the 28 patients with diabetes had adequate levels of 25(OH)D (4%).Part 2. People with CKD and additional MS had significantly lower levels of 25(OH)D (17.9±6.4 ng/ml versus 24.1±7.7 ng/ml p <0.001) and an increased likelihood of inadequate 25(OH)D<30ng / ml (96.4% vs. 70.4%, p = 0.001). Differences in 25(OH)D levels were not as expected from a corresponding decrease in 1,25(OH)2D nor in an increase in PTH or cases of secondary hyperparathyroidism (SHPT). However, only the waist circumference of the components of the MS was correlated with 25(OH)D levels (p = 0.014). No significant differentiation of 25(OH)D in patients with eGFR <60 ml/min / 1.73m2 was observed in the population with MS. In contrast, patients with MS in addition to decreased glomerular filtration had a mean decrease of 1.25(OH)2D compared with those with MS and eGFR> 60ml / min / 1.73m2 (39.2±16.1 pg/ml versus 56.7±17.7 pg/ml, p <0.001). and much higher median PTH value [92.1 (54.7, 132.9) pg / ml versus 51.6 (34.9, 80.1) pg / ml, p <0.001]. Significantly increased was also the percentage of individuals with parathormone values above this group's 64.3% (or 36 of 56) versus 30.4% (17/56). Conclusions. Levels of 25(OH)D, the main index of vitamin D body stores are lower in people with elevated body mass index and people with MS irrespectively of eGFR. However, in the case of the MS, the absence of correlation with components other than the waist circumference indicates it is more likely the presence of obesity rather than the syndrome itself is responsible for the low 25(OH)D levels.Low eGFR and not obesity or the presence of MS is the primary determinant for 1,25(OH)2D and PTH levels as well as for the incidence of SHPT. This observation raises questions as to whether low 25(OH)D levels correspond to a true vitamin D deficiency but also whether the 30ng/ml level of adequacy is high and should be re-examined. CKD affects 1,25(OH)2D and PTH levels strongly than 25(OH)D indicating that in the pathogenesis of SHPT of CKD the role of other factors such hyperphosphatemia and increased FGF-23 thus the reduced synthesis of 1,25(OH)2D, is stronger than any reduced levels of 25(OH)D.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kitsos, Athanasios
  • Κίτσος, Αθανάσιος

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/48811

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kitsos, Athanasios; Κίτσος, Αθανάσιος. Μεταβολικό σύνδρομο και οστική νόσος σε ασθενείς με χρόνια νεφρική νόσο. University of Ioannina, 2020. http://hdl.handle.net/10442/hedi/48811